9/8/2023

0.9% Sodium Chloride 10 mL, 20 mL, and 50 mL Preservative Free Vials and Syringes

Reason for the Shortage

- Fresenius Kabi has sodium chloride vials available.
- Pfizer had sodium chloride vials on shortage due to increased demand.

Available Products

- 0.9% Sodium Chloride solution for injection, Fresenius Kabi, 10 mL single dose vial, 25 count, NDC 63323-0186-10
- 0.9% Sodium Chloride solution for injection, Fresenius Kabi, 20 mL single dose vial, 25 count, NDC 63323-0186-20
- 0.9% Sodium Chloride solution for injection, Medefil, Inc., 10 mL syringe, 60 count, NDC 64253-0202-30
- 0.9% Sodium Chloride solution for injection, Pfizer, 10 mL Life-Shield single dose vial, 25 count, NDC 00409-4888-12
- 0.9% Sodium Chloride solution for injection, Pfizer, 10 mL single dose vial, 25 count, NDC 00409-4888-10
- 0.9% Sodium Chloride solution for injection, Pfizer, 20 mL single dose vial, 25 count, NDC 00409-4888-20
- 0.9% Sodium Chloride solution for injection, Pfizer, 50 mL single dose vial, 25 count, NDC 00409-4888-50

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated September 8, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 6, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.